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Abstract 
One of the mechanisms of Klebsiella pneumoniae and Escherichia coli resistance to β-lactam 
antibiotics is the production of β-lactamase enzymes. Among these are the AmpC β-lactamases, 
which confer resistance to a class of antibiotics. However, little is known about the AmpC β-
lactamases of K. pneumoniae and E. coli clinical isolates in Qazvin, Iran. This study was designed 
to assess the AmpC β-lactamases-producing strains and also identify the prevalence 
of AmpC β-lactamases genes. Antimicrobial susceptibility tests were performed on 435 K. 
pneumoniae and E. coli isolates using disk diffusion technique. Plasmid-mediated AmpC genes 
were studied using a multiplex PCR assay. The AmpC β-lactamase-producer isolates were studied 
by employing cefoxitin disk diffusion test, AmpC induction test, AmpC cefoxitin-EDTA test, and 
boronic acid disk test. Our results showed that of 46 (18.4%) cefoxitin-insensitive E. coli isolates, 
10 (21.7%) were positive for AmpC β-lactamase genes, among them 4 (8.69%) isolates were 
positive for blaDHA genes and 6 (13%) for blaCIT genes. Of 57 (30.4%) cefoxitin-insensitive K. 
pneumoniae isolates, 10 (17.5%) were positive for AmpC gene with 4 (6.34%) and 6 (9.5%) 
isolates positive for blaDHA and blaCIT genes, respectively. However, no MOX, ACC, FOX, 
or EBC genes were detected in the isolates. Considering the results of different confirmatory 
phenotypic tests, the AmpC cefoxitin-EDTA test showed a higher discriminatory power for 
detecting AmpC β-lactamase-producing strains. The specificity and sensitivity of AmpC cefoxitin-
EDTA were 77%, 100% for K. pneumonia and 70%, 90% for E. coli higher than the other two 
tests, respectively. Also, the authors demonstrated high prevalence rate for resistance to certain 
antibiotics, such as cefuroxime, trimethoprim-sulfamethoxazole, ampicillin, and cefotaxime. In 
conclusion, our study provided valuable information regarding the plasmid-mediated AmpC β-
lactamase gene content, antibiotic resistance, and confirmatory phenotypic tests for AmpC β-
lactamases in E. coli and K. pneumoniae isolates from clinical sources. 
 
